Granite Point Capital Management L.P. purchased a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,000 shares of the insurance provider’s stock, valued at approximately $1,203,000.

Other large investors have also bought and sold shares of the company. Federated Investors Inc. PA boosted its holdings in Humana by 608.1% in the second quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock valued at $8,331,000 after purchasing an additional 29,736 shares during the last quarter. Creative Planning boosted its holdings in Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after purchasing an additional 15 shares during the last quarter. Cipher Capital LP boosted its holdings in Humana by 7.7% in the second quarter. Cipher Capital LP now owns 9,734 shares of the insurance provider’s stock valued at $2,342,000 after purchasing an additional 698 shares during the last quarter. US Bancorp DE boosted its holdings in Humana by 4.4% in the second quarter. US Bancorp DE now owns 44,359 shares of the insurance provider’s stock valued at $10,674,000 after purchasing an additional 1,870 shares during the last quarter. Finally, CHURCHILL MANAGEMENT Corp purchased a new stake in Humana in the second quarter valued at $6,074,000. 95.14% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/13/granite-point-capital-management-l-p-purchases-shares-of-5000-humana-inc-hum.html.

Several research firms have commented on HUM. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $255.00 price target on the stock in a report on Tuesday, June 13th. BidaskClub lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Citigroup Inc. began coverage on shares of Humana in a report on Wednesday, June 28th. They issued a “buy” rating and a $275.00 price target on the stock. Credit Suisse Group reaffirmed an “outperform” rating and issued a $260.00 price target (up from $250.00) on shares of Humana in a report on Thursday, August 3rd. Finally, Deutsche Bank AG upped their price target on shares of Humana from $234.00 to $243.00 and gave the company a “hold” rating in a report on Monday, August 7th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $244.35.

Humana Inc. (HUM) traded down 0.535% on Wednesday, hitting $253.735. 314,152 shares of the company traded hands. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $259.76. The stock has a market cap of $36.67 billion, a PE ratio of 20.873 and a beta of 0.87. The stock’s 50-day moving average is $248.25 and its 200 day moving average is $230.58.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. The firm had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. Humana had a net margin of 3.37% and a return on equity of 15.85%. During the same quarter in the previous year, the firm earned $2.30 earnings per share. Equities research analysts expect that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Tuesday, August 29th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio is currently 13.06%.

In related news, insider Elizabeth D. Bierbower sold 9,786 shares of the business’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now owns 18,042 shares of the company’s stock, valued at $4,672,878. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP M Todoroff Christopher sold 22,935 shares of the business’s stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $252.52, for a total transaction of $5,791,546.20. Following the sale, the vice president now directly owns 24,001 shares in the company, valued at approximately $6,060,732.52. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,566 shares of company stock worth $15,326,746. 0.80% of the stock is owned by insiders.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.